Renu Gupta

Renu Gupta, M.D., is a seasoned medical professional with extensive experience in leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as Principal at GBP Consulting, LLC since October 2014 and as a Consultant and Chief Medical Officer at Adiso Therapeutics since April 2022, Renu Gupta has held significant positions at various organizations, including a member of the Board of Directors for AIM at Melanoma and Breath Therapeutics. Previously, Renu Gupta contributed as Chief Medical Officer for Promedior Inc. and Corbus Pharmaceuticals and held executive roles at Insmed Incorporated and Cerimon Pharmaceuticals. Renu Gupta's educational background includes a Doctor of Medicine degree from the University of Zambia and fellowships focused on Infectious Diseases and Immunology from esteemed institutions like the University of Pennsylvania and Children's Hospital of Philadelphia.